Tipo : |
periódico |
Enlace : |
http://www.currenttherapeuticres.com/article/S0011-393X(15)00016-8/abstract |
|
Los equipos de investigación : |
San Francisco - Theravance Biopharma |
Autores : |
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. |
Título : |
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. |
número : |
Current Ther Res ; 77: 105-110. 2015 |
|
Nivel de evidencia : |
|
La estabilidad física : |
|
Estabilidad química : |
|
otros métodos : |
|
Comentarios : |
Productos de degradación identificados y cuantificados |
|
Lista de la molécula
Telavancin hydrochloride
|
|
|
|
|
15 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
15 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
0.6 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
0.6 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|